Atika Capital Management »

Ascendis Pharma A S shares owned by Atika Capital Management

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Atika Capital Management from 13F filings

Historical chart of Atika Capital Management investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Atika Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Atika Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.3M 49k 151.17
2019-12-31 $7.2M 52k 139.13
2019-09-30 $2.4M 25k 96.34
2019-06-30 $4.7M 41k 115.13
2019-03-31 $5.4M 46k 117.70
2018-06-30 $1.0M 16k 66.50

More positions owned by Atika Capital Management

EXACT Sciences Corporation Call Option (EXAS)
Ishares Tr Rus Top 200 Etf Call Option (IWL)
NVIDIA Corporation (NVDA)
Shockwave Med (SWAV)
Microsoft Corporation (MSFT)
Vertiv Holdings Com Cl A (VRT)
Inspire Med Sys (INSP)
Amazon (AMZN)
MercadoLibre (MELI)
Eli Lilly & Co. (LLY)
Intuitive Surgical Com New (ISRG)
Rxsight (RXST)
Meta Platforms Cl A (META)
Sentinelone Cl A (S)
Appfolio Com Cl A (APPF)

View all positions for Atika Capital Management

Top funds holding Ascendis Pharma A S

RA Capital Management
Artisan Partners Limited Partnership
FMR
Westfield Capital Management Company
Henderson Group
venBio Select Advisor
Wellington Management Company
T. Rowe Price Investment Management
Franklin Resources
T. Rowe Price Associates
Massachusetts Financial Services
Sofinnova Ventures
Brown Advisory Holdings Incorporated
Spyglass Capital Management
Alliancebernstein

View all funds holding Ascendis Pharma A S